SAN DIEGO–(BUSINESS WIRE)–Element Biosciences, Inc. today announced an upsized Series E round of financing, including $175 million from longstanding investor Samsung Electronics, and an undisclosed amount from other investors. The funding will accelerate commercialization of Element’s growing ecosystem of genomic and multiomic solutions, expand its global presence, and advance its product roadmap across research, translational science, and diagnostic applications. This new capital will suppor
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
